Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Multiple Myeloma 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Lymphoma 19Leukemia, Myeloid, Acute 18Myelodysplastic Syndromes 17Lymphoma, Non-Hodgkin 14Neoplasms, Plasma Cell 12Leukemia 12Neuroblastoma 11Leukemia, Lymphocytic, Chronic, B-Cell 11Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 9Recurrence 7Melanoma 7Lymphoma, Mantle-Cell 7Hematologic Neoplasms 7Burkitt Lymphoma 7Sarcoma 6Ovarian Neoplasms 6Myeloproliferative Disorders 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Follicular 6Sarcoma, Ewing 5Neoplasm Metastasis 5Medulloblastoma 5Lymphoma, B-Cell, Marginal Zone 5Liver Neoplasms 5Wilms Tumor 4Rhabdomyosarcoma 4Retinoblastoma 4

Interventions

Temozolomide 3Cyclophosphamide 3Carboplatin 3Automobiles 3temsirolimus 2fludarabine 2entinostat 2Thiotepa 2Surgical Procedures, Operative 2Radiotherapy, Conformal 2Peripheral Blood Stem Cell Transplantation 2Filgrastim 2trametinib 1sonidegib 1ribociclib 1perillyl alcohol 1etoposide phosphate 1cixutumumab 1carboxyamido-triazole 1Vorinostat 1Vincristine 1Verteporfin 1Thalidomide 1Radiotherapy, Intensity-Modulated 1Platinum 1Paclitaxel 1ONC206 1Melphalan 1Magnetic Resonance Spectroscopy 1Isotretinoin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Pinealoma × Melphalan × Clear all
NCT00253721 2017-04-21

Melphalan With BBBD in Treating Patients With Brain Malignancies

OHSU Knight Cancer Institute

Phase 1 Terminated
21 enrolled
CNSLymphoid

Astrocytoma, Brain Neoplasms, Glioma, Lymphoma, Medulloblastoma, Neoplasm Metastasis, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡